A Study on the Characteristics of Healthy Volunteers who Participate in Phase I Clinical Trials in Korea

被引:3
作者
Seo, Ji-Hye [1 ]
Kim, Ock-Joo [1 ]
Yoo, Sang-Ho [2 ]
Choi, Eun Kyung [3 ]
Park, Ji-Eun [4 ]
机构
[1] Seoul Natl Univ, Dept Hist Med & Med Humanities, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea
[2] Hanyang Univ, Dept Med Human & Eth, Coll Med, Seoul, South Korea
[3] Korea Natl Inst Bioeth Policy, Seoul, South Korea
[4] Korea Inst Oriental Med, KM Data Div, Daejeon, South Korea
关键词
phase I clinical trials; healthy volunteers; informed consent; research ethics;
D O I
10.1177/15562646211034275
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
The phase I trial is the first step in administering a drug to humans, but it has no therapeutic purpose. Under the absence of therapeutic purpose, healthy volunteers demonstrated different motivations, unlike the actual patients participating in trials. There were many reported motivations, such as financial motivation, contributing to the health science, accessing ancillary health care benefits, scientific interest or interest in the goals of the study, meeting people, and general curiosity. The aim of this study was to identify the motivation and characteristics of healthy volunteers participating in phase I trials in the Republic of Korea. We gave surveys to 121 healthy volunteers to study their demographic characteristics and the reasons of participation. We identified whether the decision to participate in the research was influenced by demographic factors and whether the perception and attitudes toward the research were influenced by the characteristics of the healthy volunteers. After completion of the first survey, 12 healthy volunteers who had participated in a phase I clinical trial were selected to answer the second interview. According to our survey, most healthy volunteers were unmarried men and economically dependent. Most of them participated in the study because of financial reward. The most important factor to measure financial reward was the research period. Also, 43% of the volunteers were university students, 42% answered "university graduation" and 55% were residing in family-owned houses. Many healthy volunteers were found to be living in family homes and to have a student status or lack of economic independence. Results of the survey showed that 64% of respondents indicated having more than one clinical trial participation. In-depth interviews showed that healthy volunteers had diverse motivation to participate in research and that healthy volunteer perceive the clinical trial positively. The main motivation for healthy volunteers' participation in research was "financial reward." Healthy volunteers also considered research schedules, processes, and safety, and had a positive perception of clinical trials, but they thought that the public has a negative perception.
引用
收藏
页码:193 / 212
页数:20
相关论文
共 50 条
  • [21] Laboratory data in healthy volunteers: reference values, reference changes, screening and laboratory adverse event limits in Phase I clinical trials
    M. Sibille
    N. Deigat
    I. Durieu
    M. Guillaumont
    D. Morel
    J. Bienvenu
    D. Massignon
    D. Vital Durand
    European Journal of Clinical Pharmacology, 1999, 55 : 13 - 19
  • [22] What if Institutional Review Boards (IRBs) treated healthy volunteers in clinical trials as their clients?
    Tolich, Martin
    AUSTRALASIAN MEDICAL JOURNAL, 2010, 3 (12): : 767 - 771
  • [23] Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events
    Almeida, Luis
    Kashdan, Todd B.
    Nunes, Teresa
    Coelho, Rui
    Albino-Teixeira, Antonio
    Soares-da-Silva, Patricio
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (06) : 575 - 582
  • [24] Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events
    Luis Almeida
    Todd B. Kashdan
    Teresa Nunes
    Rui Coelho
    António Albino-Teixeira
    Patrício Soares-da-Silva
    European Journal of Clinical Pharmacology, 2008, 64 : 575 - 582
  • [25] Sociodemographic and psychological characteristics influencing patients' willingness to participate in clinical trials
    Gouveia, Rita
    Cruz, Vitor Tedim
    Almeida, Luis
    BMJ OPEN QUALITY, 2022, 11 (04)
  • [26] Exceptional Risk: Healthy Volunteers' Perceptions of HIV/AIDS Clinical Trials
    Cottingham, Marci D.
    Kalbaugh, Julianne M.
    Swezey, Teresa
    Fisher, Jill A.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2018, 79 : S30 - S36
  • [27] SELECTION OF HEALTHY-VOLUNTEERS FOR PHASE-I STUDIES
    SIBILLE, M
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1990, 4 : S167 - S176
  • [28] Who is willing to participate in low-risk pragmatic clinical trials without consent?
    Dal-Re, Rafael
    Carcas, Antonio J.
    Carne, Xavier
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (12) : 1557 - 1563
  • [29] Characterization of renal biomarkers for use in clinical trials: biomarker evaluation in healthy volunteers
    Brott, David A.
    Adler, Scott H.
    Arani, Ramin
    Lovick, Susan C.
    Pinches, Mark
    Furlong, Stephen T.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 227 - 237
  • [30] Healthy volunteer profile: Levels of anxiety, depression, socioeconomic aspects and candidates' motivations of participation in phase I clinical trials
    Salvatierra, Andree
    Lioba, Iris
    Perez, Marta
    Mateus, Julian
    Grau, Santiago
    Aldea-Perona, Ana
    ANSIEDAD Y ESTRES-ANXIETY AND STRESS, 2020, 26 (2-3): : 83 - 90